CLINICAL_TRIALS
trial_result
· 2009-08-31
Clinical Trial Update: Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line [Phase 2]
Summary
Phase 2 trial update on gemcitabine-based combinations for first-line metastatic breast cancer has completed, with results posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2009-08-31